or
forgot password
  • cancer clinical trials in stanford, CA

  • S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Lung Cancer
    Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Breast Cancer
    Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Breast Cancer
    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Neuroblastoma
    Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Lymphoma
    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
    Stanford Comprehensive Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Lung Cancer
    Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Colorectal Cancer
    Positron Emission Tomography in Determining Stage of Esophageal Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Esophageal Cancer
    Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Kidney Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Stanford University
    Stanford, California 94305
    Head and Neck Cancer
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma
    Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia
    Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia
    Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Small Intestine Cancer
    The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
    Stanford Univ
    Stanford, California 94305-5107
    HIV Infections, Papilloma
    Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Lymphoma
    Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Colorectal Cancer
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Bevacizumab in Treating Patients With Myelodysplastic Syndrome
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Tipifarnib in Treating Young Patients With Refractory Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Blood and Marrow Transplant Clinical Research Network
    Stanford University
    Stanford, California 94305
    Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Graft vs Host Disease
    Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Colorectal Cancer
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Brain Tumor, Central Nervous System Tumor
    Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity
    Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia, Myelodysplastic Syndromes
    Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease
    Stanford University Medical Center
    Stanford, California 94305-5408
    Graft vs Host Disease
    Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Ovarian Neoplasms
    Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lung Cancer
    Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Cancer
    Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Non-Hodgkin
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Stanford University
    Stanford, California 94305
    Ovarian Cancer
    Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
    Stanford University
    Stanford, California 94305
    Prostatic Neoplasms, Multiple Myeloma, Bladder Neoplasms, Lymphoma
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Head and Neck Cancer
    Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    Stanford University Medical Center, Division of Hematology
    Stanford, California 94305-5112
    Multiple Myeloma
    Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
    Stanford University
    Stanford, California 94305
    Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
    Stanford Hospital
    Stanford, California 94305-5208
    Beta-thalassemia, Myelodysplastic Syndromes, Fanconi Syndrome, Anemia, Diamond-Blackfan, Anemia, Aplastic
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    Stanford University
    Stanford, California 94305
    Mantle Cell Lymphoma
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Lung Cancer
    Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
    Stanford University Medical Center
    Stanford, California 94305-5408
    Myelodysplastic Syndromes
    Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
    Stanford University Medical Center
    Stanford, California 94305-5408
    Myelodysplastic Syndromes
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Treatment of Infertility in Women With Polycystic Ovary Syndrome
    Stanford University
    Stanford, California 94305
    Polycystic Ovary Syndrome, Infertility, Pregnancy
    Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lymphoma
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Lymphoma
    Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Unspecified Childhood Solid Tumor, Protocol Specific
    Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
    Stanford University Med. Ctr., Dept. of Dermatology
    Stanford, California 94305-5152
    Cutaneous T-Cell Lymphoma
    Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
    Stanford University Med Ctr., Dept of Dermatology
    Stanford, California 94305-5152
    Cutaneous T-Cell Lymphoma
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Stanford Comprehensive Cancer Center - Stanford
    Stanford, California 94305
    Sarcoma